DNA-based “liquid biopsy” could help save lives and reduce health disparities Researchers have developed a blood test that could make it possible for doctors to detect—then quickly prevent or slow down—acute heart transplant rejection, a potentially deadly condition that occurs in the early months after a patient has received a donor heart. They...
When you think of the San Francisco Bay Area, those young, tech-savvy college graduates who work for some of the world’s largest software companies there may first come to mind. But this bustling metropolitan area is also home to nearly 1.5 million people age 65 and older . So when the city went into its first lockdown in March to try to halt the...
NIH-funded study finds higher dose is not more effective at reducing serious flu complications in this high-risk group High-dose influenza (commonly known as flu) vaccines are no better than regular-dose influenza vaccines in reducing deaths and hospitalizations among patients with underlying heart disease, according to a large study publishing in...
Using a life support machine to replicate the functions of the heart and lungs significantly improved the survival of people who suffered from out-of-hospital cardiac arrest, according to a new study published today in The Lancet . The treatment program involving the life support machine called extracorporeal membrane oxygenation (ECMO) proved so...
Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not. Those with the mutation have a lower risk of diabetes, obesity, heart failure, and even death. The researchers say their finding could provide the basis for drug...
This article is the third in a three-part series about the NHLBI CADET II program. Although a variety of treatment options are available for patients with lung diseases such as asthma and chronic obstructive pulmonary disease (COPD), some patients do not respond to existing medications or experience side effects that limit the patients’ ability to...
A drug that blocks the action of a key hormone did not significantly improve a set of cardiovascular outcomes for patients with diastolic heart failure, a condition in which the heart is stiffer than normal and has problems filling with blood, according to a study supported by the National Institutes of Health. In terms of the study’s primary aim,...